C. diff. Spores and More

Caterina Oneto, MD and Paul Feuerstadt, MD

will be discussing C. difficile infections and the latest data shared focused on CDI's that was presented during Digestive Disease Week 2018 along with Clinical Trials in progress that address C.diff. infection prevention, treatments and recurrent C.diff. infection treatments.

Join your host, Nancy C. Caralla with Members of the C Diff Foundation as they discuss the education and advocacy, and support programs available to patients, families, and clinicians worldwide.

Join us with guest Kevin Hersh, Int'l Life Coach as we discuss life altering events and how to remove the anchor and replace it with a launch pad to continue moving forward.

Join our guest, Josh Haas, ACE Certified Personal Trainer, Health and Wellness Specialist, as we discuss 'C.diff. Hunger and Way to Prevent It.'

Nutrition, dietary challenges occur during any G.I. illness and long-term diagnosis. Josh will be discussing the importance of maintaining good nutrition during any illness, the ways to combat the hunger and prevent additional healthcare deficiencies from occurring. It is an outstanding episode so grab your paper and pen, your tablet, and notebook to take important notes that will help guide you and your loved ones through illnesses that disrupt normal dietary intake.

Join us with our three guests - Stools Game Creator, Gareth @StoolsGame along with Melvin Bell of @FocusGames and Dr Jonathan Sutton, Consultant Gastroenterologist at @BCUHB! Tune in at 1:00 p.m. ET and 6:00 p.m. (GMT) UK time, on Tuesday , May 29th, 2018.

Join us with our Guest, Synthetic Biologics’ Joseph Sliman, MD, MPH, Chief Medical Officer, as we discuss the Company’s novel microbiome-focused product candidates. Protection and preservation of the natural gut microbiome continues to be a key role in the prevention of certain infections and diseases, including Clostridium difficile infection (CDI) and irritable bowel disease (IBS). Synthetic Biologics is developing two lead microbiome-focused drugs poised for Phase 3 development including, SYN-004 (ribaxamase) which is designed to protect the gut microbiome from the effects of certain commonly used IV beta-lactam antibiotics for the prevention of CDI, overgrowth of pathogenic organisms and the emergence of antimicrobial resistance AMR, and SYN-010 which is intended to reduce the impact of methane producing organisms in the gut microbiome to treat an underlying cause of irritable bowel disease with constipation (IBS-C).

Join us with our guest Carolyn Twomey, BSN, RN as we discuss infection prevention, and antibiotic stewardship in health care settings.

Join Us with Guest Kevin Hersh, Int'l Health Coach helping individuals around the world reach their life-long goals during sickness and in health. If you have any questions for Kevin send them before the program for Kevin's answers to help you. [email protected]

Join us as guests Sue Barnes, RN, BSN, CIC, FAPIC, Independent and Board Certified Clinical Consultant in Infection Control and Prevention and APIC Fellow with Lori Strazdas, MPH - Public Health Liaison with Clorox Healthcare discuss the importance of C. difficile and how difficult of an infection it is to manage not only for patients but for the caretakers and loved ones. Before the patient leaves the hospitals, it is critical to understand the proper steps to reduce the spread of C. difficile spores in the home environment. In this episode, learn why it is important to focus on the home environment during and after a C. difficile infection and what can be done to reduce the risk of transmission and recurrence. Our guests will be discussing the types of disinfecting products that can be utilized to effectively kill C. diff. spores and how to use the products properly to accomplish this in the home environment.

Join us with our guest Alex Huang, founder of Quellthera, will discuss the new science that is revealing how incredibly smart and adaptable bacteria are. Our human microbiome and immune system have immensely complex interactions that have evolved over millions of years. The rapid immune response of living plant cells has shown us a strategy for stopping the attack of harmful bacteria without causing collateral damage to beneficial microflora. This reaction is also part of the human evolutionary diet and, unlike antibiotics, simultaneously moderates toxin assaults, intestinal vulnerability and inflammatory responses. Modern methods are finally enabling us to understand processes such as quorum sensing and other molecular interactions that pave the way to new medicines that can effectively address infections like C. diff. without promoting superbugs